Screening of infants and mortality due to neuroblastoma.
about
Screening with urinary dipsticks for reducing morbidity and mortalityOverview and recent advances in the treatment of neuroblastoma.Population-based screening for cancer: hope and hype.Identification of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation in association with neuroblastoma progressionDangerous and expensive screening and treatment for rare childhood diseases: the case of Krabbe disease.The "neuro" of neuroblastoma: Neuroblastoma as a neurodevelopmental disorder.Skin biopsy rates and incidence of melanoma: population based ecological studyPrinciples of cancer screening: lessons from history and study design issues.Autoantibody signature differentiates Wilms tumor patients from neuroblastoma patients.Overdiagnosis in cancer.Reflections on screening mammography and the early detection of breast cancer: A Countercurrents SeriesClinical use of tumor markers in childhood malignancies.Screening for lung cancer: in pursuit of pre-metastatic disease.Addressing overdiagnosis and overtreatment in cancer: a prescription for changeConceptualizing overdiagnosis in cancer screeningImaging in neuroblastoma: An update.Clinical significance of serum biomarkers in pediatric solid mediastinal and abdominal tumors.Urine catecholamine levels as diagnostic markers for neuroblastoma in a defined population: implications for ophthalmic practice.Mouse models of childhood cancer of the nervous systemEpidemiology and genetics of childhood cancer.Reversible adaptive plasticity: a mechanism for neuroblastoma cell heterogeneity and chemo-resistanceIs screening for prostate cancer with prostate specific antigen an appropriate public health measure?Community genetics and dignity in diversity in the Quebec Network of Genetic Medicine.Knowing me, knowing you.MYCN gene amplification is a powerful prognostic factor even in infantile neuroblastoma detected by mass screening.Effects of the Cessation of Mass Screening for Neuroblastoma at 6 Months of Age: A Population-Based Study in Osaka, Japan.Effectiveness of nationwide screening program for neuroblastoma in JapanIncidence of pediatric Horner syndrome and the risk of neuroblastoma: a population-based study.Use of Biomarkers in Screening for Cancer.Mechanisms of embryonal tumor initiation: distinct roles for MycN expression and MYCN amplification.Molecular characterization and classification of neuroblastoma.Incidence, ocular manifestations, and survival in children with neuroblastoma: a population-based study.Secular trends in neuroblastoma mortality before and after the cessation of national mass screening in Japan.Pharmacotherapy of neuroblastoma.Biomarkers in pediatrics: children as biomarker orphans.Features and outcomes of neonatal neuroblastoma.Immunocombination therapy for high-risk neuroblastoma.Mechanisms of neuroblastoma regressionEmerging treatment options for the treatment of neuroblastoma: potential role of perifosine.Clinical research on rare diseases of children: neuroblastoma.
P2860
Q24186492-642E0890-9CC3-4E26-AE75-09CBC36089DCQ30238693-D7D79BF4-607E-465C-9E49-3AAF44D40F43Q30251601-888A56DA-44DA-4AB9-8E7F-11F46264E508Q30955037-A3AD88DC-60D8-4EF6-B8F3-6E1CB5CC6DA3Q33583245-A23A6DFB-FD35-499F-A23B-070966AD99E4Q33643120-C1E266A1-DAB6-4A6F-8763-2E313912EC4BQ33941763-794FE3A1-88E6-41FC-949A-D0B1077E1362Q34065705-FD293926-47BA-435F-B6D4-3D3D61836823Q34110567-2C065CC7-46F2-4787-8D0C-4EC34E9C1991Q34111655-6C0AAD99-DD66-49F9-9490-15508C4FE84BQ34305881-1B884C23-0CE4-4CBB-8B43-B4C0A18C6A7AQ35009328-BADB9698-E668-4E60-8055-EF2CE286420BQ35037686-EB34D09A-786F-48A0-AF5E-4E29D7481FB5Q35067706-F12C5911-4BB2-4CE8-B598-D7236DAEDD73Q35102637-D8A80325-3B00-4E20-AEB1-6695519989DFQ35568727-1D370B07-A52C-4952-9337-E01DBA9E1135Q35719602-6304D340-ED8D-4E61-9744-B53F37054512Q35751604-87475F94-6FA8-4DD9-AF36-B5996A5D85ADQ35786003-C34551A8-00C7-4A89-9920-A7CAC7697573Q35868038-FAB1FC82-138B-4C1E-86D9-F4A374CD19ADQ36144256-C46C77AC-C55F-4B3A-90D2-4AA56B3DDFF6Q36217132-088FCBC7-B13A-4E41-924C-FC0E691AEEE3Q36495089-D5F6D63A-9984-4E3D-8D07-1E989C1FCC18Q36570194-FE631913-E073-4214-8BA2-2CCCEBFCE3EAQ36614178-BD6464BE-B182-44DC-AE57-B2CF44B9673FQ36731569-C08D42AC-C541-4904-86B2-08CC6281B5F9Q36779472-F5269CFF-03FA-4955-AE0C-A2EB44E040DCQ37095562-450B9AB9-BEDD-4AC9-944C-5C2061D470F0Q37155019-F65944B6-CB0D-4395-A596-93E22909AEE1Q37494210-B147BE74-3C91-463C-B819-E0BC545DCB8EQ37515355-C591FD99-28DC-4845-8E3E-25273E8BCE5AQ37528555-FE01EE5D-56D3-41C4-A31B-0DE5B822B1A7Q37583261-3BC4A29E-DD7F-4E40-AC53-924CE38E5C7FQ37735199-C15AEEE1-FDB0-4E3F-B15F-460BE042BD8EQ37817271-82389A08-EA8C-4736-8FA3-EA3700957A6AQ37895172-847C7162-1BB3-4D2D-9F49-DB0523416196Q37991024-BCDEEEFF-24B9-4F4B-82A1-71D1A35D9836Q38261519-9CD566E5-1CF9-4B68-B5D3-34BE19844E7EQ38474631-08492264-D60F-4125-8ABF-7804E25F4966Q38791761-AB6BBB16-4D5B-47F8-99B1-09BC944F410D
P2860
Screening of infants and mortality due to neuroblastoma.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Screening of infants and mortality due to neuroblastoma.
@ast
Screening of infants and mortality due to neuroblastoma.
@en
Screening of infants and mortality due to neuroblastoma.
@nl
type
label
Screening of infants and mortality due to neuroblastoma.
@ast
Screening of infants and mortality due to neuroblastoma.
@en
Screening of infants and mortality due to neuroblastoma.
@nl
prefLabel
Screening of infants and mortality due to neuroblastoma.
@ast
Screening of infants and mortality due to neuroblastoma.
@en
Screening of infants and mortality due to neuroblastoma.
@nl
P2093
P356
P1476
Screening of infants and mortality due to neuroblastoma.
@en
P2093
Bernard Lemieux
Geoffrey Dougherty
Greta Bunin
Jonathan J Shuster
Josee Brossard
Leslie L Robison
Mark Bernstein
Mendel Tuchman
Ru-Nie Gao
P304
P356
10.1056/NEJMOA012387
P407
P577
2002-04-01T00:00:00Z